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Clinics and pathology 
Disease 
ANLL and therapy related ANLL; mainly with 
preceding MDS. 
Phenotype / cell stem origin 
M1 or M2 ANLL. 
Epidemiology 
Rare: five available cases herein reviewed, 4 adults 
(42-70 yrs) and one child; 1M/4F. 
Clinics 
Blood data: pancytopenia. 
Prognosis 




Found in three cases; +8 twice. 
Genes involved and Proteins 






DNA / RNA 
Transcription is from telomere to centromere. 
Protein 
Contains a Runt domain and, in the C-term, a 
transactivation domain; forms heterodimers; widely 
expressed; nuclear localisation; transcription factor 
(activator) for various hematopoietic-specific genes. 
References 
Berger R, Le Coniat M, Romana SP, Jonveaux P. Secondary 
acute myeloblastic leukemia with t(16;21)(q24;q22) involving 
the AML1 gene. Hematol Cell Ther 1996;38:183-186. 
Shimada M, Ohtsuka E, Shimizu T, Matsumoto T, Matsushita 
K, Tanimoto F, Kajii T. A recurrent translocation, 
t(16;21)(q24;q22), associated with acute myelogenous 
leukemia: identification by fluorescence in situ hybridization. 
Cancer Genet Cytogenet 1997;96:102-105. 
This article should be referenced as such: 
Pérot C. t(16;21)(q24;q22). Atlas Genet Cytogenet Oncol 
Haematol.1998;2(3):104. 
 
 
 
 
 
 
 
 
 
 
